The United States is a central context shaping global drug policy, psychedelic research, and debates around traditional plant medicines. Content on this tag covers US legal frameworks affecting people’s access to ayahuasca and other traditional medicines — including religious exemptions for Santo Daime and UDV — harm reduction approaches, research developments, and the cultural and political dynamics around psychedelic-assisted therapies.
